ARTICLE | Clinical News
AM211: Interim Phase I data
July 6, 2009 7:00 AM UTC
Interim results from a blinded Phase I trial in healthy volunteers showed a single dose of oral AM211 had a sustained pharmacodynamic effect. In addition, blood concentrations of AM211 were found to b...